Wojciech Jurczak

Statistics

Publications

175

Citations

19.8K

H-Index

Active since

1999

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Jagiellonian University

The University of Texas MD Anderson Cancer Center

Vita-Salute San Raffaele University

IRCCS Ospedale San Raffaele

Wojciech Jurczak is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

1999–2025

175

Publications

175

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Medicine, Hematology, Pharmacology +17

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Ajay K. Gopal, Brad S. Kahl, Sven de Vos et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig et al. · The Lancet Oncology · 2016 · 796 citations · Full text

Medicine, Hematology, Immunology +7

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Joseph M. Connors, Wojciech Jurczak, David J. Straus et al. · New England Journal of Medicine · 2017 · 764 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

1–5 of 175